Kohjin Bio Statistics
Total Valuation
Kohjin Bio has a market cap or net worth of JPY 2.96 billion. The enterprise value is 2.26 billion.
Important Dates
The last earnings date was Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Mar 30, 2027 |
Share Statistics
Kohjin Bio has 5.11 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 5.11M |
| Shares Outstanding | 5.11M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 53.99% |
| Owned by Institutions (%) | 19.05% |
| Float | 1.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | 17.86 |
| P/OCF Ratio | 4.19 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 6.21, with an EV/FCF ratio of 13.83.
| EV / Earnings | n/a |
| EV / Sales | 0.56 |
| EV / EBITDA | 6.21 |
| EV / EBIT | 270.51 |
| EV / FCF | 13.83 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.73 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 5.88 |
| Debt / FCF | 12.50 |
| Interest Coverage | -0.23 |
Financial Efficiency
Return on equity (ROE) is -0.50% and return on invested capital (ROIC) is -0.17%.
| Return on Equity (ROE) | -0.50% |
| Return on Assets (ROA) | -0.06% |
| Return on Invested Capital (ROIC) | -0.17% |
| Return on Capital Employed (ROCE) | -0.14% |
| Weighted Average Cost of Capital (WACC) | 3.20% |
| Revenue Per Employee | 24.90M |
| Profits Per Employee | -164,773 |
| Employee Count | 176 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.32 |
Taxes
In the past 12 months, Kohjin Bio has paid 20.00 million in taxes.
| Income Tax | 20.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.73% in the last 52 weeks. The beta is 0.03, so Kohjin Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | -61.73% |
| 50-Day Moving Average | 782.42 |
| 200-Day Moving Average | 1,033.48 |
| Relative Strength Index (RSI) | 16.83 |
| Average Volume (20 Days) | 4,155 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kohjin Bio had revenue of JPY 4.38 billion and -29.00 million in losses. Loss per share was -5.67.
| Revenue | 4.38B |
| Gross Profit | 1.47B |
| Operating Income | -9.00M |
| Pretax Income | -9.00M |
| Net Income | -29.00M |
| EBITDA | 374.00M |
| EBIT | -9.00M |
| Loss Per Share | -5.67 |
Full Income Statement Balance Sheet
The company has 2.91 billion in cash and 2.20 billion in debt, with a net cash position of 709.00 million or 138.70 per share.
| Cash & Cash Equivalents | 2.91B |
| Total Debt | 2.20B |
| Net Cash | 709.00M |
| Net Cash Per Share | 138.70 |
| Equity (Book Value) | 5.87B |
| Book Value Per Share | 1,148.96 |
| Working Capital | 1.90B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 750.00 million and capital expenditures -574.00 million, giving a free cash flow of 176.00 million.
| Operating Cash Flow | 750.00M |
| Capital Expenditures | -574.00M |
| Depreciation & Amortization | 383.00M |
| Net Borrowing | 247.00M |
| Free Cash Flow | 176.00M |
| FCF Per Share | 34.43 |
Full Cash Flow Statement Margins
Gross margin is 33.61%, with operating and profit margins of -0.21% and -0.66%.
| Gross Margin | 33.61% |
| Operating Margin | -0.21% |
| Pretax Margin | -0.21% |
| Profit Margin | -0.66% |
| EBITDA Margin | 8.53% |
| EBIT Margin | -0.21% |
| FCF Margin | 4.02% |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 1.72%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 1.72% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 19.97% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | 1.62% |
| Earnings Yield | -0.98% |
| FCF Yield | 5.60% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kohjin Bio has an Altman Z-Score of 2.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.42 |
| Piotroski F-Score | 3 |